emerging opportunities in myanmar's diagnostic imaging and in-vitro diagnostics

MyanMar’s Diagnostic iMaging & in-vitro Diagnostics

Solidiance has produced this white paper for information purposes only. While every effort has been made to ensure the accuracy of the information and data contained herein, Solidiance bears no responsibility for any possible errors and omissions. All information, views, and advice are given in good faith but without any legal responsibility; the information contained should not be regarded as a substitute for legal and/or commercial advice. Copyright restrictions (including those of third parties) are to be observed.

DEcEMBEr 2015

EmErging OppOrtunitiEs in

solidiance

2 | www.solidiance.com

ExEcutivE summary myanmar’s HEaltHcarE EcOnOmics

3 4

15 Diagnostic imaging (Di) in myanmar: market potentials

21

28

29

33

34

37

in-vitro Diagnostics (ivD) in myanmar: market challenges

registration & licensing of Diagnostic imaging (Di) anD in-vitro Diagnostic (ivD) equipment

casE studiEs

key takeaways

inFOgrapHic

aBOut us

contEnt

www.solidiance.com | 3

Economic growth and demographic changes in Myanmar are driving healthcare spending throughout the country. Myanmar’s total healthcare expenditure is set to cross USD 2 billion for FY 2015-2016.

Rapid growth in healthcare demand is inevitably resulting in the development of the healthcare system. There is also growing awareness of regular health check-ups for early detection of non-communicable diseases.

Diagnostic Imaging & In-Vitro Diagnostics have witnessed quick penetration into Myanmar since 2012. However, demand is increasing faster than supply and global healthcare players need to adapt to a fast evolving market. Myanmar presents a set of unique growth opportunities for global healthcare players and a sustainable long-term strategy is required to capitalize on these opportunities.

ExEcutivEsuMMary


MyanMar’sHEaltHcarE EconoMics


Percentage of contribution from government to total healthcare expenditure has grown from 12% in 2010 to 40% in 2014

• 2.7% of total government budget was allocated to healthcare in 2014• Government proposed a plan in parliament in January 2015 to increase healthcare budget allocation with an

annual growth rate of 6% until 2020

619 790 922 1,041 1,146

85

118

456

572

757

2010 2011 2012 2013 2014

Private Spending Public Spending

908

1,378

704

1,613

1,903 27.5

13.04

1.9

14.1 17.2

11.16

MyanMar’s ToTal HealTHcare expendiTure spliT (usd Mn)

Source: World Health Organization (WHO), Ministry of Health (MOH), Solidiance Research and Analysis

coMparison of ToTal HealTHcare expendiTure in usd Bn (2014)


Myanmar has the lowest healthcare spending in Southeast Asia

3.1%

4.0%

4.6% 4.6%

6.0%

2.7%

• Around 70% of Myanmar’s population stay in rural areas with minimal access to healthcare services that are primarily concentrated in the big cities: Yangon, Mandalay, and Nay Pyi Taw

• Majority of the increase in healthcare expenditure is targeted to tier-2 cities

107

423

35

2,507

264 111

MyanMar’s HealTHcare expendiTure (% of Gdp) – 2014

coMparison of per capiTa ToTal HealTHcare expendiTure (usd) – 2014

Indonesia

Malaysia

Myanmar

Singapore

Thailand

Vietnam

Source: Solidiance Research & Analysis, WHO, MOH


Out-of-pocket (OOP) expenses are mainly used for self-prescribed medicine, diagnostics and private clinics.

Public hospitals are subsidizing costs of diagnostics and providing medicine for the most needed people.

Under the Social Security Scheme, all employers and employees who contribute to the scheme are entitled to healthcare benefits and treatment in certain hospitals which are listed by Social Security Board.

International NGOs (INGO) are financially supporting to strengthen primary healthcare services and facilities in rural areas.

In July 2015, the Myanmar government approved to sell “Health Insurance” to the public through Myanmar’s Insurance and 12 private insurance companies.• Cost of one health insurance unit is MMK 50,000, or

approximately USD 45 – and a person can buy up to 5 units• The coverage of healthcare expenses for one unit of health

insurance is mainly for hospitalization expenses, which is MMK 15,000 per day for five times in 30-day period of hospitalization (up to 150 days)

out-of-pocket payment is the key dominant source for healthcare financing, accounting for 78% of the total healthcare expenditure in Myanmar

OOP

Public & Government Hospitals

INGO

Social Security Scheme

78%

15%

6%

1%

MyanMar’s HealTH expendiTure By financinG aGenTs, 2014

MyanMar’s new HealTH insurance scHeMe

Source: Ministry of Health (MOH), Solidiance Interviews and Analysis


Effects of increased government spending in the last 2 years can be seen in the public hospitals in Myanmar’s tier 2 & tier 3 cities

69% 7%

3% 3%

2%

14% 1%

Public Primary Care Hospitals

Public Secondary Care Hospitals

Public Tertiary care Hospitals

Military Hospitals

Government's Ministry Hospitals

Private General Hospitals

Traditional Medicine Hospitals

MyanMar’s Type of HospiTals By level, 2014 (1,192 HospiTals)

Source: WHO, Health System Review 2014 Report from MOH, Solidiance Research and Analysis


93%

7%

Public sector

Private sector

HospiTal Beds in MyanMar By secTor, 2014 (73,040 Beds)

Public tertiary care hospitals are catering to specialized medical treatments and services in big cities like Yangon, Mandalay, Nay Pyi Taw, and Taunggyi.

The Ministries of Railways, Labour, Mines, Industry, Energy & Cooperatives as well as Home Affairs are providing medical care and treatment to their employees through their own run hospitals.

The majority of hospitals are providing basic x-ray and ultrasound services.Source: WHO, Health System Review 2014 Report, MOH, Solidiance Research and Analysis


Private hospitals account for 14% of total hospitals and contribute to 7% of total beds in Myanmar

850 1,000

1,184 1,025

950 316 135

167

Public Hospitals Private Hospitals

Public hospitals account for ~86% of hospitals but are far behind regional quality standards.

In public hospitals, selected medicines and lab tests are being offered for free to the less fortunate since in the late 2014.

Private hospitals have increased in number by 10% between 2011 and 2014.

Source: Central Statistical Organization, MOH, Myanmar Private Hospitals’ Association, Solidiance Research & Analysis

nuMBer of HospiTals in MyanMar - 2014


0 20 40 60 80 100 120 140 160

Shan State

Sagaing Region

Yangon Region

Mandalay Region

Bago Region

Ayeyawady Region

Magway Region

Kachin State

Rakhine State

Mon State

Taninthayi Region

Kayin State

Nay Pyi Taw

Chin State

Kayah State

Public Hospitals

Private Hospitals

MyanMar’s privaTe and puBlic HospiTal disTriBuTion across THe counTry, 2014

Source: Central Statistical Organization, MOH, Myanmar Private Hospitals Association, Solidiance Research & Analysis


Half of the private hospitals in Yangon have less than 25 beds

32%

15%

4%

50% >200 100-200

25-100 <25

yanGon HospiTals By nuMBer of Beds, 2014

Number of beds Number of hospitals

<25 25

25-99 20

100-200 4

>200 3

total 52

# Name of the Hospital # of beds

1 Pinlon 300

2 Asia Royal 232

3 Shwe Gon Dine Specialist Centre (SSC) 200

4 Sakura 150

5 Bahosi 120

6 Pun Hlaing 100

7 Witoriya 100

8 Aung Yadanar 70

9 Ma Har Mying 70

10 Parami 65

11 Green Cross Specialist 50

12 Thu Kha Kabar 50

13 Shin Par Ku 49

14 Academy 40


15 Thiri Sandar 38

16 Shwe La Min 34

17 Rose Hill 30

18 Kaung 25

19 Aye Myittar 25

20 Aye Myittar (Baby Clinics) 25

21 Aye Yeik Thar 25

22 Kant Kaw Diagnostic & Neuro Centre 25

23 Kaung Myat Mon 25

24 Myat Tar 25

25 Royal 25

26 Shwe Baho 25

27 Win 25

Advanced diagnostic tests are only offered in large hospitals (>100 beds)

lisT of HospiTals wiTH ≥ 25 Beds in yanGon, 2014

Source: Solidiance Research & Analysis, Central Statistical Organization, Ministry of Health, Myanmar Private Hospitals Association


Most of the private hospitals in Mandalay and Nay Pyi Taw have less than 25 beds

lisT of HospiTals wiTH ≥ 25 Beds in Mandalay in 2014

Mandalay HospiTals By no. of Beds, 2014

nay pyi Taw HospiTals By no. of Beds, 2014

lisT of HospiTals wiTH ≥ 25 Beds in Mandalay in 2014


1 Nyein 120

2 City 100

3 Kant Kaw 80

4 Mandalar 55

5 Myat Thu Kha 50

6 Thit Sar 45

7 Ar Yaw Jan 25

8 Aye Thiri 25

9 Chan Nyein Aung 25

10 Hans 25


1 Outara Thiri 250

2 Bawga Theiddhi 40

3 Kaung Thit 25

50%

2,8%

8,34% 14,58%

100 - 300 25 - 99 <25

1,14%

2,29% 4,57%

100 - 300 25 - 99 <25

Source: Solidiance Research & Analysis, Central Statistical Organization, Ministry of Health, Myanmar Private Hospitals Association


Number of death by non-communicable diseases (NCD) has increased by 7% between 2010 & 2014 in Myanmar

125.3

45.8

27

8.7

35.7

110.25

48.51 39.69

13.23

48.51

CVD Cancers Respiratory diseases

Diabetes Other NCD

2010 2014

242.5 260.2

368 181

2010 2014

Other deaths

Non-communicable diseases

nuMBer of deaTH By non-coMMunicaBle diseases IN MYANMAR(in THousand)

nuMBer of deaTH By causes IN MYANMAR

(in THousand)

Proportion of deaths by NCD has increased from 40% in 2010 to 59% in 2014.

Increasing trend of chronic diseases suggests severe need for better diagnostic services.

The government has developed a comprehensive national policy for prevention and control of major NCDs. Priority is given to early detection of major NCDs by upgrading and installing advanced medical devices to address burden of premature deaths.

Source: National Statistical Office, Solidiance Research & Analysis


Diagnostic iMaging (Di) in MyanMar:

MarkEt potEntials


Number of Diagnostic imaging (Di) tests conducted in Myanmar’s private facilities has seen a big forward jump since 2012

• Basic diagnostic imaging tests such as x-ray & ultrasound are free in public hospitals for in-patients• Military hospitals have advanced devices but these are primarily for military personnel and their families• Patients in Yangon prefer to take diagnostic imaging tests in private hospitals due to 24-hour service

availability and better accuracy of results• Basic diagnostic imaging tests such as X-ray and Ultrasound can be done in private diagnostic clinics• In public hospitals, advanced diagnostic imaging devices like MRI & CT are only installed in large specialty

hospitals in major cities

MyanMar’s sHare of diaGnosTic iMaGinG TesTs By faciliTies in 2014

Source: Solidiance Interviews & Analysis

45%

24%

20%

11%

Public hospitals

Private hospitals

Military hospitals

Private diagnostic clinics


Increasing awareness about NCD has resulted in increasing demand for Di in Myanmar

NCDs are identified as the major cause of mortality - accounting for around 60% of total death in 2014.

Estimated 60,000 cancer cases are identified each year in Myanmar. Breast cancer at 17%, is the most common cancer in women while lung cancer is the common in men.

Majority of deaths by NCD are due to non-detection in early stages which is directly related to diagnostic imaging.

MorTaliTy raTe By Type in MyanMar (2014)

Top cancer cases in MyanMar (2014)

Source: Central Statistical Organization, WHO, Solidiance Interviews & Analysis

Communicable maternal, perinatal and nutritional conditions, Cardiovascular diseases

Cancer

Other NCDs

Injuries

Chronic respiratory diseases

Diabetes

30%

25% 11%

11%

11%

9% 3%

38%

17%

16%

15%

5% 5% 4%

Breast

Lung, Bronchus, Trachea

Cervix Uteri

Stomach

Non Hodgkin's lymphoma

Oesophagus

Others


Victoria Hospital, one of the big private hospitals in Myanmar, offers all diagnostic imaging tests

advanced Di equipment is only available in public tertiary hospitals and big private hospitals in main cities like Yangon, Mandalay, Nay Pyi Taw, and Taung Gyi

Thailand

X-ray

Myanmar

1,474

941

1,198

800

692

52

157

12

Ultrasound

CT

MRI

nuMBer of insTalled MacHines in MyanMar, 2015

Most public hospitals are equipped with 2D Ultrasound machines while 3D, 4D & Doppler machines are mostly found in private hospitals.

30 CT scanners were added to public hospitals in 2013 – most of which were second-hand machines from Japan & Singapore.

MRI scanners are only available at five public hospitals and seven private hospitals in Myanmar.



Name of the Hospital Public hospitals

Military hospitals

Private hospitals

Private diagnostic clinics

X-ray

3D/4D Ultrasound

CT -

MRI -

Radiation Therapy -

Bone Scan/Dexa Scan

Mammo

ECG/Echo Scan

Color-Doppler

Radiography (Radio/Fluoro)

Trans-Vg (TVS)

Fibroscan

Comparison of key Diagnostic imaging (Di) modalities in Myanmar

Source: Solidiance Research & Analysis, Ministry of Health, Myanmar Private Hospitals Association


Radiologist, Asia Royal Hospital

at Myanmar’s public hospitals, diagnostic imaging tests are free for inpatients. Outpatients still need to pay - but considerably cheaper than in private facilities

Type of services Public Private/ Diagnostic Clinic

DI services

MRI scan USD 60 USD 190

CT scan 64-slice : USD 40128-slice: USD 40 128-slice: USD 200

X-ray scan USD 3 USD 10

Ultrasound USD 3 USD 10

Average wait time Both MRI & CT scans 2-3 weeks About 4 hours to a day

Average age of device All Devices 60% > 5 years old40% < 5 years old

70% > 5 years old30% < 5 years old

“Compared to developed countries, cost of diagnostic imaging services in Myanmar is still affordable. A major barrier to the upgrade of equipment is patient’s limited spending power as new and advanced machines will increase prices.

Source: MOH, Solidiance Interviews and Analysis


in-vitro Diagnostics

(ivD) in MyanMar:

MarkEt cHallEngEs


private facilities are leading IVD testing in Myanmar

60% 20%

16%

3% 1%

Private Laboratories

Private Hospitals

Public Hospitals

Foreign branches

Public Laboratories

diaGnosTic cenTers in MyanMar, 2015 ~ 200 (ToTal)

• Nearly all private laboratories are standalone with 40% market share in medical check-ups and laboratory testing services

• There are only two standalone public laboratories, each in Yangon & Mandalay

• A limited number of large private hospitals have their own laboratories providing services ranging from basic medical check-up to specific intensive testing

More than half of the population in the three major cities in Myanmar are from middle-income class, hence large private hospitals and standalone laboratories are concentrated in these cities only. A few foreign hospitals have testing centers in Yangon, however, these are only for patients that are referred by a parent hospital in the originating country.

Due to high outbound medical tourism to Thailand, Bangkok Hospital & Bumrungrad International Hospital have set up testing centers in Yangon to cater to after-care needs of their patients.




Myanmar is facing population pressure with increasing proportion of people above 60 years old.

Growing usage of modern IVD is essential to reduce cost and increase operational efficiency for the healthcare facilities.

Furthermore, sedentary lifestyle, unhealthy eating habits and lack of regular check-up has led to high prevalence of diabetes, hypertension and cervical cancer.

7.0% 7.4% 7.8% 8.2% 8.6% 9.0% 9.4% 9.8% 10.2% 10.6%

13.8%

0.0%

2.0%

4.0%

6.0%

8.0%

10.0%

12.0%

14.0%

16.0%

2013 2014 2015f 2016f 2017f 2018f 2019f 2020f 2021f 2022f 2030f

increased penetration of ivD in Myanmar is due to growing aging population and high prevalence of major diseases

percenTaGe of MyanMar’s populaTion >60 years old

diaBeTes prevalence raTe

HyperTension prevalence raTe

cervical cancer incidence raTe

• 6% nationwide• 12% in rural population• Over 1 million are

undiagnosed

• 23.8% nationwide• Nearly 3.5 million are

undiagnosed

• 2.5% in Myanmar while Southeast Asia’s average is 1.7%, mainly due to lack of early diagnosis


the number of laboratories in Myanmar has increased in the last 3 years, but it is still

insufficient to meet growing demand

Key laboratories offering IVD tests in Myanmar

Hospitals Standalone local laboratories

Foreign laboratories

Key distributors in Myanmar’s medical devices industry

The majority of the tests are performed in the standalone local labs due to the affordability and the perceived accuracy of the test results. Doctors usually refer outpatients to have the specialty tests performed at standalone clinics.

On the other hand, foreign labs have been entering Myanmar since 2010.

DKSH is the leading distributor for pharmaceutical products and medical devices in Myanmar. DKSH has been in Myanmar for over 15 years - currently distributing brands like Roche & Novartis.

Sealion is also a key distributor and has had partnerships with GE healthcare, Johnson & Johnson, Festo, 3M and Medtronic.

Mega Lifesciences entered Myanmar in 1995. The rest of other local medical devices distributors include Myanmar Zircon, Okkar Thiri and Medi Power.



Some key IVD tests in Myanmar

IVD Tests Sub-Category Test Private Public

Molecular Diagnostic • Quantitative tests (HBV, HCV, HIV, HPV) • USD 100-150 (per test) • USD 0-20 (per test)

Biochemistry

• Liver profile • Renal profile • Lipid profile • Protein test • Cardiac profile • Diabetes Test • Other tests

• USD 20 – 40 (for basic profiling tests)

• USD 50 - 120 (for screening package)

• USD 0-15 • No screening package

Immunology

• Quantitative test• Screening test • Hormones • Tumor markers • Rheumatology

• USD 10 – 30 (for antibody tests such as HBV, HIV, Malaria and etc.)

• USD 0-7 (for specific tests for antibody)

Haematology • Coagulation screening• Iron study

• USD 7 (basic Rh Check- blood protein test)

• USD 0-1.5 (basic RH check)

Microbiology • Culture & Sensitivity• Routine examination • USD 5 (Urine (RE) test) • USD 0-1 (Urine (RE)

test)

Histopathology • Cytology (Fluid, Sputum) • Tissue biopsy

• USD 10-12 (Biopsy test; each tissue sample from 1-3 cm)

• USD 0-1 (Urine (RE) test)



though majority of the ivD tests are done in Myanmar, people still opt to do tests abroad for specific diseases for better accuracy

Most of the basic IVD tests are done in Myanmar. However, to ensure accuracy, upper middle class (which represents ~10% of the population) get their IVD tests for specific diseases such as detailed tissue biopsy, tumor marker and C1 esterase inhibitor in Thailand and Singapore.

Doctor, SSC Hospital

“In Myanmar, there is little spending on IVD due to limited awareness of the usage and its benefits. However, with increasing outreach of media and health education programs, IVD will see significant growth in the next 3-5 years.


of total healthcare budget is used for IVD in Myanmar

of total healthcare budget is used for IVD in ASEAN-5*

Director, Private Laboratory

“

<1%2% - 3%

Biochemistry tests are the majority of IVD tests done in Myanmar with its basic screening packages such as liver, renal, cardiac, and diabetes profiling tests. Microbiology and Immunology are closely linked and often difficult to distinguish. These 2 combined are one-third of the total tests. Molecular diagnostic is a very small market and we need to increase its penetration.

ivd BudGeT allocaTion in MyanMar in 2014

percenTaGe spliT of ivd TesTs done in MyanMar in 2014

40%

20%

15%

10%

10% 5%

Biochemisry Immunology Microbiology

Hematology Molecular Diagnostics Histopathology

*ASEAN 5 includes Indonesia, Malaysia, Philippines, Thailand, and Vietnam



rEgistration & licEnsing of Diagnostic iMaging (Di) anD in-vitro

Diagnostic (ivD) EquipMEnt

Compared with complex and long registration of pharmaceutical products, registration for imaging devices and medical equipment is quite simple and normally takes 2-3 months

• All in-vitro-diagnostics equipment is required to apply for quality check and license from FDA.

• Medical imaging devices like X-rays, MRI and CT scanners are exempted from FDA license as no formal medical devices law has been passed yet

• Timeline is up to 3 months

• Medical Association MPMEEA (Myanmar Pharmaceutical and Medical Equipment Entrepreneurs Association) has the price and control check on newly applied medical imaging devices and IVDs. it works with ministries of health and commerce for recommendation

• Timeline is up to 1-2 weeks

• After quality and price check of new products, MPMEEA sends recommendation to Department of Trade to register products with Ministry of Commerce with required documents such as test manual, country of origin and COA (certificate of evaluation analysis)

• Timeline is up to 1-2 weeks

Source: Food and Drug Administration, Ministry of Commerce, MPMEEA, Solidiance Research & Analysis

fda: approval

license

MpMeea: price conTrol

cHeck

depT. of Trade: reGisTraTion


casE stuDiEs


asia royal HospitalAsia Royal Hospital is a leading private hospital in the heart of Yangon city

Some IVD devices at Asia Royal Hospital

• Cobas e411 • Sysmex (XT 2001, CA-50, XT

2000i) • Pentra 60+ • Liza (300 Plus, 300 Hyel) • Vitros ECI • Minividasi • Partec SL3• VITEK2 Compact 30 • BACT/ALERT 3D 60

• Cyflow Counter-Partec • Easylite Plus / Plus (Na/K/

CL Analyser) • Haemocue Hb200 (+) /

Albumin 201• SYSXT-4000i • Mini Vidas • Urometer 120 • C311 • Option 2+

established :2000 (One of the first private hospitals in Myanmar)

occupancy rate : >90% (2013) for 232 beds

outpatient rate : ~250,000 (per year)

inpatient rate : ~11,000 (per year)

Di & ivD services : Available

33%

25%

18%

11%

9% 4% USA

Japan

France

Germany

China

Sweden

ivd - insTalled Base in asia royal HospiTal By counTry of oriGin (as of auG 2015)

Doctor, Asia Royal Hospital

“Most of the tests conducted in private hospital laboratories are basic tests for medical screening packages in biochemistry. But speciality tests such as immunology and biopsy are mostly referred to private laboratories.

Source: Asia Royal Hospital, Solidiance Interviews & Analysis


diaGnosTic iMaGinG devices - insTalled Base in asia royal HospiTal By counTry of oriGin (as of auG 2015)

Types of DI device Model of devices

X-ray• 630 mA Shimazu• 550 mA Siemens• 330 mA Siemens

Portable X-ray 250 mA

C-Arm X-Ray Siremobile Siemens

CT Scanner Somatom Sensation 64 SliceEmotion DUO

ECG

Cardiofax 6511Schiller AT1/CH 6340Schiller AT1Cardiofax 96 20L

Echo Scanner

Echo Cardiogram (S-2000)Acuson X 300CypressUSSH 140a

Ultrasound4D Ultrasound (X-300)G 20EUB405B

33%

25%

18%

11% Germany

U.S.A

Switzerland

Japan



yangon gEnEral Hospital (ygH)• YGH is a major public hospital, providing 24 specialized treatments

and is the best teaching hospital in Myanmar• Yangon General Hospital is one of the five public hospitals equipped

with MRI scanners• Fewer number of CT & MRI machines is causing long waiting time and

results are also delayed by up to 2 weeks.• In early 2014, YGH installed new equipment from Varian Medical

Systems and procured new medical linear accelerator technology for high-dose-rate brachytherapy for cancer treatment


Hospitals providing Radiation Therapy in Myanmar (as of 2015)

yangon general hospital (yangon) public

Mandalay General Hospital (Mandalay) Public

Sao San Htun Hospital (Taungyi) Public

Nay Pyi Taw Hospital. (Nay Pyi Taw) Public

Pin Lon Hospital (Yangon) Private

• 1,500 beds• 24 specialized departments• Emergency care for general medicine, general surgery and

traumatology• Staff: Approximately 300 doctors and over 400 nurses• Teaching hospitals of University of Medicine 1, Yangon Institute

of Nursing and University of Paramedical Science• 123 staff in Radiology Department

yanGon General HospiTal


kEy takEaways

Shifts in Myanmar’s healthcare system are creating emerging opportunities for private healthcare companies across the country, but it requires them to have a long term strategic view of the market.

Major demographic changes and fast income growth have affected a significant increase in demand for Diagnostic Imaging & In-Vitro Diagnostics. However, market still requires efforts in increasing awareness about non-communicable diseases and effects of specialized testing.

Pricing is a key challenge that needs immediate attention especially in the private sector. Local hospitals, clinics & laboratories need assistance from global healthcare companies in devising a value proposition that would be appealing to the patients.

Myanmar patients spent ~USD 210 million in 2014 on outbound medical tourism. This is a large patient base that can be tapped in Myanmar to meet their diagnostics needs.


$$ $$$$

has the lowest healthcare spending in Southeast Asia.

total healthcare expenditure

Take up 14% of total hospitals 50% of private hospitals have <25 beds

Only available in public tertiary hospitals & big private hospitals

but IVD tests for some specific diseases are done abroad for accuracy

are leading the IVD market

Diagnostic Imaging (DI)In-vitro Diagnostics

Demands are rising for :

of Myanmar’s population reside in rural areas with minimal access to healthcare services

Death by non-communicable diseases (NCD)

Drivers of IVD penetration increase

Most IVD tests are done in Myanmar

2,7%

70%

40%

7%

in 2014 on outbound medical tourism

Only

to cross

of GDP in 2014

for 2015 - 2016

(2010 - 2014)

share

Patients spent

$$ ~ USD 210 millionMyanmar

Myanmar's

USD 2 billion

Private hospitals

Take up ~86% of total hospitals Quality is far behind regional standards

Due to non-detection in early stages Suggesting need for better diagnostic services

Growing aging populationHigh prevalence of major diseases (diabetes, hypertension, cervical cancer)

Public hospitals

Private facilities

Myanmar hospitals

Myanmaris a large patient

base for healthcare

$

$$ $$

PASSPORTMyanmar'sHealthcare

overview

HOSPITAL

increased by

Advanced diagnostics

Myanmar'sDiagnostic

ImagingMARKET

Myanmar'sIN-VITRO

DiagnosticMARKET

Source: Solidiance, www.solidiance.com


auTHorsOmar Aziz | Associate PartnerOmar Aziz is an Associate Partner at Solidiance. Equipped with over 9 years of experience in consulting, he has managed large projects in pharmaceutical, healthcare devices & healthcare infrastructure domain. His expertise are in helping multinational clients understand the Asian market landscape by profiling industries and competition, sizing the markets, segmenting customers, analyzing distribution channels, preparing investment feasibility studies, identifying suppliers, reviewing potential joint ventures or acquisitions, and delivering market entry and growth strategy in Asia. Omar speaks regularly at healthcare conferences, most recently, he conducted a workshop on ‘Myanmar Hospital Build’ at ‘2nd Healthcare Facilities Asia 2015’.

Shin Thant Aung | AnalystShin Thant is an Analyst based in Solidiance’s Yangon office in Myanmar. He is a part of Solidiance’s healthcare practice and has worked on a number of key projects. He understands the distribution scenario & regulatory frameworks for healthcare products and maintains good relations with key distributors and government agencies. Prior to joining Soildiance, he had been working as an advisory associate in a top four global accounting and consulting firm. Shin holds a Bachelor of Science degree in applied accounting from Oxford Brookes University.

Mie Ko | AnalystMie Ko is an Analyst based in Solidiance’s Yangon office in Myanmar. Mie Ko worked on several projects for Solidiance in Myanmar where she supported feasibility studies and investment projects for Fortune 500 companies. Prior to joining our team, she worked at the Finance Department of a large hospitality group in Yangon. Mie Ko holds an MBA with specialization in Strategic International Marketing from the Asian Institute of Technology.


what we Do

Soldiance is a corporate strategy consulting firm with focus on Asia Pacific. We advise CEOs on make-or-break deals, define new business models and accelerate Asia growth. Through our 10 offices across Asia, we provide our clients with a better understanding of intrinsic regional issues. To learn more about how Solidiance has helped many Fortune 500 & Asian Conglomerates to succeed in Asia, please visit:

http://www.solidiance.com/clients.

what we are focusing on

Our industry experience is centered on healthcare, industrial applications, clean technology, and technology. Our Asian market entry and growth strategy services provide the required insights and the necessary roadmap to capture a profitable market share in the region.

additional Details

Solidiance has offices in China, India, Indonesia, Malaysia, Myanmar, Philippines, Singapore, Thailand, UAE and Vietnam. We are fast expanding and always on the lookout for exceptional people.

aBout us


solidiance

chinaSuite 2101, Hong Kong Plaza, No 283 Middle Huaihai Road,Shanghai 200021Phone: +86 21 5113 2131

indonesiaOleos I Building6th FLoor - Unit 612Jl. Mampang Prapatan RayaNo. 139A, Jakarta 12950 Phone : +62 21 7918 0330

Myanmar4th Floor, Shwe Gon Plaza Kabar Aye Pagoda RoadBahan Township, YangonMyanmar - 11201Phone: +95 979 700 6465

singaporeSuite 07-05High Street Centre, 1 North Bridge RoadSingapore 179094Phone: + 65 31520301

uaESuite 402D - Dark Green Building, TwoFour54Sheikh Zayed RoadOpposite Khalifa ParkAbu Dhabi, United Arab EmiratesPO Box 769338Phone: +971 (0) 24 420 420

indiaSuite M-38/1 3/Floor, IBC Tower. Middle Circle, Connaught Place, New Delhi – 110001Phone: +91 11 4152 7888

Malaysia23A-02 Binjai 8 Premium SOHO, 8 Lorong BinjaiKuala Lumpur 50450Phone: +60 3 21 810 692

philippinesUnit 2105, Tycoon Centre Pearl Drive, Ortigas Centre Pasig City, Metro ManilaPhone: +63 2531 8346

thailandInterchange Tower 21#2109 - 21F399 Sukhumvit RoadNorth Klongtoey, WattanaBangkok 10110Phone: +66 26112664

vietnamSuite 704, Satra Dong Khoi Building58 Dong Khoi streetDistrict 1, Ho Chi Minh CityPhone: +84 835218639

Website:http://www.solidiance.com

Email:[email protected]

our offices